NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Is There Still Value in Amgen After Its Strong 2025 Share Price Run?

Wondering if Amgen’s share price already reflects the upside, or if there is still value on the table? You are not alone, and this article is going to tackle that head on from an investor’s perspective. Amgen’s stock has quietly put in a solid run, with the price up 1.9% over the last week and 27.8% year to date, even after a small 1.8% pullback over the last month that reminds us risk perceptions can change quickly. Recent attention has centered on Amgen’s expanding pipeline in areas like...
NYSE:ITW
NYSE:ITWMachinery

Illinois Tool Works (ITW): Is the Quiet Grind Higher Backed by Its Current Valuation?

Illinois Tool Works (ITW) has been quietly grinding higher this month, and that slow climb is catching investors attention. With steady earnings growth and a long dividend track record, the stock invites a closer look. See our latest analysis for Illinois Tool Works. At around $251.57 per share, Illinois Tool Works is treading water in the short term, with a modestly positive year to date share price return but a much stronger three year total shareholder return suggesting the longer term...